MRK
Merck & Co.Previous close
144.91
Change
+1.12 / +0.78%
52-Week Range
77.58 – 156.92
P/E (TTM)
112.2
Forward P/E
19.5
Based on consensus earnings for the next 12 months
Market Cap
$358B
1M
+6.57%
S&P 500 −2.41% over same period
Volume / Avg Volume
7.2M / 7.9M
0.92× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-08-04 | $16.6B | -0.13 / -0.27 | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-30 | $16.3B | -1.28 / -1.52 | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-03 | — | — / — | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-30 | — | — / — | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-29 | — | — / — | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-24 | — | — / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 81 of its 5-year rangeExpensive
5-year range 11.6 – 901.4 · Median 21.0
Last 4 quarters: $4.2B in buybacks + $8.3B in dividends, 3.50% of market cap combined
P/E (TTM)
112.2
P/B
8.5
P/S
5.4
Dividend Yield
2.87%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.7% on average on the first trading day after, rising 4 times
Most recent +0.26%
Volatility & Correlation
1-year beta 0.18 · Correlation with S&P 500 0.08Low beta
Annualized volatility 30% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 9 · $30.0MNet selling $30.0M
- 08-13Guindo ChirfiEVP, Access, Policy & CommsSell$1.4M10,000 shares · Avg price 135.00
- 08-12DeLuca Richard R.EVP&Pres, Merck Animal HeallthSell$1.5M11,699 shares · 2 trades · Avg price 131.63
- 08-12Zachary JenniferEVP, General CounselSell$10.7M80,315 shares · Avg price 133.46
- 08-11DeLuca Richard R.EVP&Pres, Merck Animal HeallthSell$1.7M12,837 shares · 2 trades · Avg price 131.76
- 08-10DeLuca Richard R.EVP&Pres, Merck Animal HeallthSell$2.7M20,784 shares · Avg price 130.43
- 08-06Guindo ChirfiEVP, Access, Policy & CommsSell$2.0M15,000 shares · Avg price 131.00
- 08-06DeLuca Richard R.EVP&Pres, Merck Animal HeallthSell$0.79M6,050 shares · 3 trades · Avg price 130.38
- 08-05Williams David MichaelEVP,Chief Info&Digital OfficerSell$6.8M52,847 shares · 3 trades · Avg price 128.77
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 16.61 | +5.1% | 73.5% | -1.34 | -0.54 |
| FY2026 Q1 | 16.29 | +4.9% | 74.2% | -4.24 | -1.72 |
| FY2025 Q4 | 16.40 | +5.0% | 66.2% | 2.96 | 1.19 |
| FY2025 Q3 | 17.28 | +3.7% | 77.7% | 5.79 | 2.32 |
| FY2025 Q2 | 15.81 | −1.9% | 77.5% | 4.43 | 1.76 |
| FY2025 Q1 | 15.53 | −1.6% | 78.0% | 5.08 | 2.01 |
| FY2024 Q4 | 15.62 | +6.8% | 75.5% | 3.74 | 1.49 |
| FY2024 Q3 | 16.66 | +4.4% | 75.5% | 3.16 | 1.24 |
| FY2024 Q2 | 16.11 | +7.2% | 76.8% | 5.46 | 2.14 |
| FY2024 Q1 | 15.78 | +8.9% | 77.6% | 4.76 | 1.87 |
| FY2023 Q4 | 14.63 | +5.8% | 73.3% | -1.23 | -0.48 |
| FY2023 Q3 | 15.96 | +6.7% | 73.3% | 4.75 | 1.86 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| MRK | 112.2 | +5.1% | 73.5% | +6.57% | Neutral |
| LLY | 39.9 | +47.7% | 85.8% | −3.83% | Bullish |
| JNJ | 30.6 | +6.6% | 68.2% | +1.87% | Bullish |
| ABBV | 73.7 | +10.2% | 74.7% | +4.87% | Neutral |
| UNH | 23.9 | +0.4% | 88.1% | −5.15% | Neutral |
| TMO | 34.4 | +10.5% | — | +10.75% | Bullish |
| AMGN | 23.3 | +9.5% | 72.0% | −10.26% | Neutral |
| GILD | — | +10.2% | 79.8% | +6.31% | Neutral |
| ABT | 33.2 | +7.8% | 56.2% | −7.26% | Neutral |